After finishing at $19.81 in the prior trading day, Cassava Sciences Inc (NASDAQ: SAVA) closed at $19.70, down -0.56%. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 559998 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our goal is to gain a better understanding of SAVA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.13 and its Current Ratio is at 9.13. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 15, 2021, Cantor Fitzgerald Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $100.
Maxim Group reiterated its Buy rating for the stock on July 07, 2021, while the target price for the stock was revised from $80 to $190.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 23 ’23 when ROBERTSON SANFORD bought 30,000 shares for $17.45 per share. The transaction valued at 523,500 led to the insider holds 886,851 shares of the business.
Barry Richard bought 16,571 shares of SAVA for $275,907 on Aug 22 ’23. The Director now owns 293,477 shares after completing the transaction at $16.65 per share. On Aug 21 ’23, another insider, Barry Richard, who serves as the Director of the company, bought 1,906 shares for $16.80 each. As a result, the insider paid 32,021 and bolstered with 276,906 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SAVA now has a Market Capitalization of 855.86M and an Enterprise Value of 734.72M.
Stock Price History:
Over the past 52 weeks, SAVA has reached a high of $32.10, while it has fallen to a 52-week low of $12.32. The 50-Day Moving Average of the stock is 23.06, while the 200-Day Moving Average is calculated to be 21.59.
Shares Statistics:
The stock has traded on average 714.73K shares per day over the past 3-months and 684.06k shares per day over the last 10 days, according to various share statistics. A total of 42.24M shares are outstanding, with a floating share count of 39.16M. Insiders hold about 9.40% of the company’s shares, while institutions hold 32.69% stake in the company. Shares short for SAVA as of Feb 29, 2024 were 11.32M with a Short Ratio of 15.84, compared to 12.18M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 26.18% and a Short% of Float of 27.74%.
Earnings Estimates
Its stock is currently analyzed by 2 different market analysts. On average, analysts expect EPS of -$0.46 for the current quarter, with a high estimate of -$0.41 and a low estimate of -$0.51, while EPS last year was -$0.58. The consensus estimate for the next quarter is -$0.45, with high estimates of -$0.42 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$2.01 and -$2.28 for the fiscal current year, implying an average EPS of -$2.14. EPS for the following year is -$0.47, with 2 analysts recommending between $1.67 and -$2.62.
